Over 60% of adults value being notified about AI in healthcare, underscoring the importance of transparency and ethical considerations in health systems.
FTC highlights new concern over ‘pay-to-delay’ deals that determine when generics are sold
In a recent report, the U.S. Federal Trade Commission released an update on patent settlements between brand-name and generic drug makers, but for the first